CytomX stock is rising higher on Wednesday as CTMX investors get an update on its upcoming earnings and clinical trial news. More
Articles
JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits
Johnson & Johnson stock is up on Wednesday as JNJ investors learn of plans for a $6.5 billion settlement to its talc lawsuits. More
Wedbush Just Slashed Its Price Target on Starbucks (SBUX) Stock
SBUX stock is in focus after Wedbush cut its price target on the company. Starbucks CEO Laxman Narasimhan faces a host of problems. More
Wedbush Just Raised Its Price Target on Pinterest (PINS) Stock
Pinterest stock is up on Wednesday after PINS shares got a new price target from Wedbush alongside its Q1 earnings beat. More
GSK Stock Earnings: GSK Beats EPS, Beats Revenue for Q1 2024
GSK stock results show that GSK beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
ENTG Stock Earnings: Entegris Beats EPS, Misses Revenue for Q1 2024
ENTG stock results show that Entegris beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
SITE Stock Earnings: SiteOne Landscape Supply Misses EPS, Beats Revenue for Q1 2024
SITE stock results show that SiteOne Landscape Supply missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More
